Cancer Diagnostics Market to be Worth $162.57 Billion by 2030: Grand View Research, Inc.

Read 240-page market research report, "Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT, Imaging), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read 240-page market research report, " Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT, Imaging),...

Read 240-page market research report, "Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT, Imaging), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research.

Cancer Diagnostics Market Growth & Trends

Several countries have thus undertaken measures to increase screening for early diagnosis and help existing patients. For instance, Ayushman Bharat and the Prime Minister's National Relief Fund was initiated by the Indian government for patients who require assistance during the treatment. Similarly, the Indian government's Department of Biotechnology signed a contract with Cancer Research UK to conduct research for affordable approaches to diagnosis and treatment.

Liquid biopsy solutions are being increasingly adopted as MCED tests as they are easily accessible for clinical applications. In recent years, they have gained regulatory approval with comprehensive and multi-cancer diagnostic approaches. Breakthrough advancements in the field and ongoing studies for early detection are contributing to market growth. Moreover, technologies such as circulating tumor DNA, extracellular vesicles, and circulating tumor cells are paving the way for better cancer care. Versatile technologies can provide integrated solutions for maximizing the potential of liquid biopsy.

Advantage of using companion diagnostics is the overall reduction in time and costs incurred by pharmaceutical and diagnostic companies. The time required to develop and commercialize a novel molecule generally consists of 10 to 15 years. Co-development of diagnostics and drugs facilitates accelerated regulatory approval processes, which significantly reduces costs. . Since the FDA guidance draft for the development of an IVD companion diagnostic device with a therapeutic product was published in 2016, many manufacturers encourage the development of companion diagnostic assays in the field of oncology. This is anticipated to positively impact market growth during the forecast period.

Cancer Diagnostics Market Report Scope

 

Cancer Diagnostics Market Segmentation 

Grand View Research has segmented the global cancer diagnostics market based on product, type, application, end-use, test type, and region

Cancer Diagnostics Market - Product Outlook (Revenue, USD Billion, 2018 - 2030)

Cancer Diagnostics Market - Type Outlook (Revenue, USD Billion, 2018 - 2030)

Cancer Diagnostics Market - Application Outlook (Revenue, USD Billion, 2018 - 2030)

Cancer Diagnostics Market - End-use Outlook (Revenue, USD Billion, 2018 - 2030)

Cancer Diagnostics Market - Test Type Outlook (Revenue, USD Billion, 2018 - 2030)

Cancer Diagnostics Market - Regional Outlook (Revenue, USD Billion, 2018 - 2030)

List of Key Players in the Cancer Diagnostics Market

Check out more market research studies published by Grand View Research:  

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Grand View Compass | Astra ESG Solutions
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/cancer-diagnostics-market-to-be-worth-162-57-billion-by-2030-grand-view-research-inc-301884991.html